FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

120636005: Loteprednol etabonate ophthalmic preparation (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    177396017 Loteprednol etabonate ophthalmic preparation en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    1185950016 Loteprednol etabonate ophthalmic preparation (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
    3376401000005118 loteprednoletabonatpræparat til oftalmisk anvendelse da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    loteprednoletabonatpræparat til oftalmisk anvendelse Is a antiinflammatorisk præparat til oftalmisk anvendelse false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse Is a Corticosteroid and/or corticosteroid derivative-containing product false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse Is a loteprednoletabonat false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Loteprednol etabonate (substance) false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. binyrehormonmiddel false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. glucocorticoidhormon false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    loteprednoletabonatpræparat til oftalmisk anvendelse Is a Product manufactured as ocular dose form (product) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Loteprednol etabonate 5 mg/mL eye suspension Is a False loteprednoletabonatpræparat til oftalmisk anvendelse Inferred relationship Some
    Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Is a False loteprednoletabonatpræparat til oftalmisk anvendelse Inferred relationship Some
    loteprednoletabonat + tobramycin Is a False loteprednoletabonatpræparat til oftalmisk anvendelse Inferred relationship Some
    Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a False loteprednoletabonatpræparat til oftalmisk anvendelse Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start